Sorrento Therapeutics Inc (SRNE)

[stocktrademan]

$SRNE recent news/filings

bearish 7.97

## source: finance.yahoo.com

Mon, 16 Nov 2015 11:28:45 GMT ~ SORRENTO THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report


read full: http://biz.yahoo.com/e/151116/srne10-q.html
*********************************************************

Wed, 28 Oct 2015 15:09:41 GMT ~ SORRENTO THERAPEUTICS, INC. Files SEC form 8-K, Other Events


read full: http://biz.yahoo.com/e/151028/srne8-k.html
*********************************************************

Mon, 19 Oct 2015 16:40:32 GMT ~ SORRENTO THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits


read full: http://biz.yahoo.com/e/151019/srne8-k.html
*********************************************************

Mon, 19 Oct 2015 10:21:16 GMT ~ Sorrento Expands its Executive Management Team with Appointment of Dr. Jeffrey Su as Chief Operating Officer to Lead its in-house Bioprocess and Manufacturing Operations

[at noodls] - SAN DIEGO, Oct. 19, 2015/PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a clinical-stage oncology company developing new treatments for cancer and associated pain, announced today ...

read full: http://www.noodls.com/view/596A6B6ED9277EED278EE31C8D5D79C7EE8EA02E
*********************************************************

Mon, 19 Oct 2015 10:00:00 GMT ~ Sorrento Expands its Executive Management Team with Appointment of Dr. Jeffrey Su as Chief Operating Officer to Lead its in-house Bioprocess and Manufacturing Operations

[PR Newswire] - Sorrento), a clinical-stage oncology company developing new treatments for cancer and associated pain, announced today the addition of Jeffrey Su, Ph.D., as Executive Vice President and Chief Operating Officer. "I am delighted that Dr. Su will join our management team. Dr. Su is a highly experienced executive with a proven track record of productivity and accomplishments in biological product development and manufacturing," said Henry Ji, Ph.D., President and Chief Executive Officer of Sorrento.

read full: http://finance.yahoo.com/news/sorrento-expands-executive-management-team-100000391.html
*********************************************************

$SRNE charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$SRNE company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/SRNE/company-info
Ticker: $SRNE
OTC Market Place: Not Available
CIK code: 0000850261
Company name: Sorrento Therapeutics, Inc.
Company website: http://www.sorrentotherapeutics.com
Incorporated In: DE, USA

Business Description: Sorrento Therapeutics, Inc. (STI) provides access to its novel and proprietary technology platform for the construction of fully human antibody libraries, the STI Technology. The STI Technology applies RNA transcription for the amplification of human immunoglobin variable domain sequences.

$SRNE share structure

## source: otcmarkets.com

Market Value: $311,533,076 a/o Nov 16, 2015
Shares Outstanding: 37,761,585 a/o Aug 03, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

$SRNE extra dd links

Company name: Sorrento Therapeutics, Inc.
Company website: http://www.sorrentotherapeutics.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/SRNE/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/SRNE/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=SRNE+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=SRNE+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=SRNE+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/SRNE/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/SRNE/news - http://finance.yahoo.com/q/h?s=SRNE+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/SRNE/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/SRNE/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/SRNE/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/SRNE/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/SRNE/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/SRNE/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/SRNE/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/SRNE/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=SRNE+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/SRNE
DTCC (dtcc.com): http://search2.dtcc.com/?q=Sorrento+Therapeutics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Sorrento+Therapeutics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Sorrento+Therapeutics%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.sorrentotherapeutics.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.sorrentotherapeutics.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.sorrentotherapeutics.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/SRNE/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/SRNE
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/SRNE/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/SRNE/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/SRNE/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000850261&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/SRNE/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/SRNE/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/SRNE/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/SRNE/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=SRNE&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=SRNE
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/SRNE/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=SRNE+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=SRNE+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=SRNE
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=SRNE
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=SRNE+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/SRNE/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=SRNE+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/SRNE.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=SRNE
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/SRNE/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/SRNE/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/SRNE/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/SRNE/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/SRNE
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/SRNE
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/SRNE:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=SRNE
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=SRNE



$SRNE DD Notes ~ http://www.ddnotesmaker.com/SRNE